Change search criteria ↓

Search results

39 projects found matching your search criteria:

  1. 1. Photodynamic therapy combined with PD-1/PD-L1 blockade immunotherapy: new possibilities for the treatment of immunogenic…

    Principal investigator: dr hab. Janusz Marcin Dąbrowski

    Uniwersytet Jagielloński, Wydział Chemii

    Call: OPUS 19, Panel: NZ7

  2. 2. LLT1 as a regulator of the immune response and a dual-target immunotherapy approach in colorectal cancer directed at NK …

    Principal investigator: dr Marzena Dorota Lenart

    Uniwersytet Jagielloński

    Call: OPUS 29, Panel: NZ6

  3. 3. Evaluation of the activity of MDM2-p53 antagonist RG7388 in mouse cancer models, alone and in combination with anti-PD-1…

    Principal investigator: Aneta Sylwia Nieznańska

    Uniwersytet Jagielloński, Wydział Chemii

    Call: PRELUDIUM 18, Panel: NZ5

  4. 4. The expression of complement inhibitors in ovarian and corpus uteri cancers - a new perspective for immunotherapy

    Principal investigator: dr hab. Lucyna Kapka-Skrzypczak

    Wyższa Szkoła Informatyki i Zarządzania w Rzeszowie, Wydział Turystyki i Nauk o Zdrowiu

    Call: SONATA 1, Panel: NZ7

  5. 5. M. bovis BCG extracellular vesicles as an alternative in bladder cancer immunotherapy

    Principal investigator: Jakub Smoliński

    Instytut Immunologii i Terapii Doświadczalnej im. Ludwika Hirszfelda Polskiej Akademii Nauk

    Call: PRELUDIUM 24, Panel: NZ7

  6. 6. New Horizons in Cancer Immunotherapy: Blocking LAG-3/FGL1 Interactions

    Principal investigator: dr Jacek Plewka

    Uniwersytet Jagielloński

    Call: SONATA 20, Panel: NZ7

  7. 7. Increasing sensitivity to immunotherapy in lung cancer via immunostimulation and modulation of tumor microenvironment

    Principal investigator: dr Urszula Oleksiewicz

    Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu

    Call: SONATA BIS 13, Panel: NZ5

  8. 8. Spatial Determinants of Immunotherapy Resistance in Cancer

    Principal investigator: dr Marcin Tabaka

    Instytut Chemii Fizycznej Polskiej Akademii Nauk, Międzynarodowe Centrum Badań Oka

    Call: WEAVE-UNISONO, Panel: NZ6

  9. 9. Small molecule modulators of the tumor necrosis factor alpha signaling pathway for the inhibition of inflammatory proces…

    Principal investigator: prof. Tadeusz Holak

    Uniwersytet Gdański

    Call: OPUS 27, Panel: NZ7

  10. 10. Tyrosine-modified polyethylenimine polymers as a promising vectors for siRNA delivery in synergistic cancer immunotherap…

    Principal investigator: Małgorzata Kubczak

    Uniwersytet Łódzki, Wydział Biologii i Ochrony Środowiska

    Call: PRELUDIUM 19, Panel: NZ5

  11. 11. The role of arginase-1 in antitumor efficacy of cancer immunotherapy using checkpoint inhibitors

    Principal investigator: prof. Dominika Anna Nowis

    Uniwersytet Warszawski, Centrum Nowych Technologii Uniwersytetu Warszawskiego

    Call: OPUS 12, Panel: NZ6

  12. 12. Development of novel anti-cancer immunotherapy against mesothelioma comprising of oncolytic adenovirus vectors armed wit…

    Principal investigator: dr Łukasz Kuryk

    Narodowy Instytut Zdrowia Publicznego - Państwowy Zakład Higieny (NIZP - PZH)

    Call: SONATA 18, Panel: NZ7

  13. 13. A smart stride for cancer: synergistic effect of co-delivery chemo- andphototherapeutic agents using magneto-fluorescent…

    Principal investigator: dr Prachi Uttam Ghoderao

    Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu

    Call: POLONEZ BIS 2, Panel: NZ7

  14. 14. Analysis of immungenecity and therapeutic activity of cell cancer vaccines based on cancer stem cells and induced plurip…

    Principal investigator: prof. Andrzej Mackiewicz

    Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu, Wydział Lekarski II

    Call: OPUS 4, Panel: NZ6

  15. 15. Next-Generation Exosome Therapy: Engineering NK Cell-Derived Vesicles for Targeted Cancer Treatment

    Principal investigator: dr Daria Nawrocka

    Instytut Immunologii i Terapii Doświadczalnej im. Ludwika Hirszfelda Polskiej Akademii Nauk

    Call: SONATINA 9, Panel: NZ6

  16. 16. Induction of human colon cancer cells apoptosis in vitro and in vivo by Tumour Necrosis Factor-Related Apoptosis-Inducin…

    Principal investigator: dr hab. Jarosław Tomasz Baran

    Uniwersytet Jagielloński- Collegium Medicum, Collegium Medicum; Wydział Lekarski

    Call: OPUS 8, Panel: NZ5

  17. 17. Neutrophil Dynamics: Unveiling Anti-Tumor and Therapy Efficacy with the TUmor Neutrophil Immunotherapy on Chip (TUNIC) m…

    Principal investigator: dr Martin Nurmik

    Międzynarodowy Instytut Mechanizmów i Maszyn Molekularnych Polskiej Akademii Nauk

    Call: SONATA 20, Panel: NZ6

  18. 18. Harnessing NK cells and Graphene Oxide Nanoparticles for Pancreatic Ductal Adenocarcinoma Immunotherapy

    Principal investigator: prof. Iwona Maria Inkielewicz-Stępniak

    Gdański Uniwersytet Medyczny

    Call: OPUS 28 (LAP), Panel: NZ7

  19. 19. Neutrophil-targeted immune response as an effective approach in immunotherapyof gastrointestinal cancers

    Principal investigator: dr Damian Jacenik

    Uniwersytet Łódzki

    Call: OPUS 27, Panel: NZ5

  20. 20. Intrinsic tumour radiosensitivity as a marker of chemoradiotherapy-induced immunogenic effects in rectal cancer

    Principal investigator: Zuzanna Maria Nowicka-Kaszkowiak

    Uniwersytet Medyczny w Łodzi, Wydział Lekarski

    Call: PRELUDIUM 21, Panel: NZ5

  21. 21. Extracellular vesicles carrying microRNA in experimental immunotherapy for glioblastoma

    Principal investigator: dr Jakub Godlewski

    Instytut Medycyny Doświadczalnej i Klinicznej im. Mirosława Mossakowskiego PAN

    Call: OPUS 21, Panel: NZ6

  22. 22. Molecular and cellular landscape of pulmonary and hepatic metastases of colorectal cancer with potential clinical implic…

    Principal investigator: dr Marta Aleksandra Popęda

    Gdański Uniwersytet Medyczny, Wydział Lekarski

    Call: PRELUDIUM 20, Panel: NZ4

  23. 23. The clinical significance of immunosuppression in ovarian cancer microenvironments

    Principal investigator: dr Anna Maria Pawłowska-Łachut

    Uniwersytet Medyczny w Lublinie

    Call: PRELUDIUM 20, Panel: NZ6

  24. 24. Comprehensive characterization of tumor immune contexture changes induced by cytotoxic agents in non-small cell lung can…

    Principal investigator: prof. Wojciech Maksymilian Fendler

    Uniwersytet Medyczny w Łodzi

    Call: PRELUDIUM BIS 2, Panel: NZ5

  25. 25. Increasing the precision of chimeric antigen receptor (CAR)-mediated anticancer immunotherapy by using the chemokine-ind…

    Principal investigator: dr hab. Radosław Zagożdżon

    Warszawski Uniwersytet Medyczny

    Call: OPUS 19, Panel: NZ6

  26. 26. Analysis of the effectiveness of glioblastoma immunotherapy using gamma-delta T cells

    Principal investigator: dr hab. Grzegorz Jacek Chodaczek

    Sieć Badawcza ŁUKASIEWICZ - PORT Polski Ośrodek Rozwoju Technologii

    Call: OPUS 18, Panel: NZ6

  27. 27. The role of interferon lambda (IFN-L) in development of immunological anti-tumour mechanizm during proggression of canin…

    Principal investigator: dr Joanna Milena Mucha

    Szkoła Główna Gospodarstwa Wiejskiego w Warszawie, Instytut Medycyny Weterynaryjnej

    Call: SONATA 12, Panel: NZ5

  28. 28. Immune response profile assessment after stereotactic radiotherapy for lung cancer.

    Principal investigator: dr hab. Renata Ewa Zaucha

    Gdański Uniwersytet Medyczny, Wydział Lekarski

    Call: OPUS 4, Panel: NZ5

  29. 29. Investigation of the mechanism of enhanced liposome delivery to tumors and its application for dual target immunotherapy

    Principal investigator: dr hab. Tomasz Piotr Rygiel

    Instytut Medycyny Doświadczalnej i Klinicznej im. Mirosława Mossakowskiego PAN

    Call: OPUS 28, Panel: NZ7

  30. 30. Extracellular vesicles modified ex vivo as an anti-cancer immune-response boosting vaccine

    Principal investigator: Klaudia Elżbieta Kiel

    Instytut Medycyny Doświadczalnej i Klinicznej im. Mirosława Mossakowskiego PAN

    Call: PRELUDIUM 20, Panel: NZ6

  31. 31. Modulation of exosome production to support anti-cancer treatment

    Principal investigator: dr Liliana Monika Czernek

    Centrum Badań Molekularnych i Makromolekularnych PAN

    Call: OPUS 18, Panel: NZ7

  32. 32. New approaches to characterize Th17/Treg cell balance contributing to anti-tumour immune responses

    Principal investigator: dr Zhi Jane Chen

    Uniwersytet Gdański, Międzynarodowe Centrum Badań nad Szczepionkami Przeciwnowotworowymi

    Call: SHENG 1, Panel: NZ6

  33. 33. Controlling the covalent activity of a PD-L1 inhibitors with light

    Principal investigator: Wiktor Jan Uzar

    Uniwersytet Jagielloński

    Call: PRELUDIUM 23, Panel: NZ7

  34. 34. CAR(dio)-T(oxicity)- Engineered Heart Tissue model for CAR-T cardiotoxicity evaluation

    Principal investigator: dr Agnieszka Joanna Zimna

    Instytut Genetyki Człowieka PAN

    Call: SONATA 19, Panel: NZ7

  35. 35. Use of comparative oncology approach to dissect the PD-1 intrinsic signalling in osteosarcoma. Can dog be the key for ne…

    Principal investigator: Katarzyna Joanna Dziubek

    Uniwersytet Gdański, Międzynarodowe Centrum Badań nad Szczepionkami Przeciwnowotworowymi

    Call: PRELUDIUM 21, Panel: NZ1

  36. 36. The SAR analysis and synthesis of complex, small molecule PD-1/PD-L1 interaction antagonists

    Principal investigator: Magdalena Maria Żarnik

    Uniwersytet Jagielloński, Wydział Chemii

    Call: PRELUDIUM 20, Panel: ST4

  37. 37. Modulation of immune cells activity in the tumor microenvironment by oligonucleotide therapeutics delivered by silk nano…

    Principal investigator: prof. Hanna Dams-Kozłowska

    Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu

    Call: OPUS 19, Panel: NZ6

  38. 38. STING protein activation combined with anti-vascular agent as a novel strategy for anticancer therapy

    Principal investigator: dr hab. Ryszard Smolarczyk

    Centrum Onkologii - Instytut im. Marii Skłodowskiej-Curie, Oddział w Gliwicach

    Call: OPUS 16, Panel: NZ5

  39. 39. Structural studies of signaling receptors HVEM/CD160 as potential targets for immunoterapy against melanoma

    Principal investigator: dr Marta Orlikowska

    Uniwersytet Gdański, Wydział Chemii

    Call: SONATA 11, Panel: NZ1

Graphic design and implementation: Jakub Piotrowski